Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
NanoViricides, Inc. (NNVC)
USD1.72
-0.05 (-2.75%)
US AMEX Healthcare Biotechnology
Address
1 Controls Drive 6484
Shelton, CT, US
Shelton, CT, US
CEO
Anil R. Diwan
Website
nanoviricides.com
IPO
2005-10-26
CIK 1379006 ISIN US6300873022
Description
NanoViricides, Inc. operates as a nano-biopharmaceutical entity, specializing in the research, development, and market introduction of pharmaceutical solutions to combat viral infections. The company's robust product pipeline includes a Human Coronavirus Program, specifically engineered to tackle both COVID-19 and various seasonal coronaviruses. For herpes-related conditions, it offers HerpeCide in multiple forms: dermal topical and eye drops to treat ailments such as shingles, postherpetic neuralgia (PHN), chickenpox, recurrent herpes labialis, genital herpes, and ocular herpes keratitis. An intraocular injectable version of HerpeCide is also under development for viral acute retinal necrosis. Another significant therapeutic candidate is FluCide, a broad-spectrum anti-influenza nanoviricide, designed for both hospitalized patients via injection and outpatients through an oral formulation. NanoViricides also develops specialized nanoviricide eye drops for viral diseases affecting the external eye, DengueCide for various strains of Dengue viruses, and HIVCide, an anti-HIV nanoviricide specifically engineered to resist viral escape. Furthermore, the company is actively advancing additional nanoviricide drug projects targeting a diverse range of viruses and indications, alongside expanding its HerpeCide program to encompass a broader spectrum of herpes viruses and associated conditions. NanoViricides, Inc. was established in 2005 and maintains its corporate headquarters in Shelton, Connecticut.
News Sentiment (7d)
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD1.72
-0.05 (-2.75%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
904.4K
Beta
1.64
Float Shares
17.50M
Free Float %
97.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -14.94% | -8.07% | +8.03% | +43.69% | +1.37% | +30.97% | +1.37% | +34.55% | -56.47% | -95.43% | -95.77% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (1 ratings, all time)
Buy
Price Targets & DCF
Current price
1.72
DCF (Unlevered)
0.03
-98.4%
DCF (Levered)
0.10
-94.0%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-21.60
Distress
Piotroski F-Score
1 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
5 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%—
-
EPS growth Biotechnology: +29.7%+10.0% Q1'26: +34.2% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%—
-
EBIT margin Biotechnology: +0.0%—
-
ROIC Biotechnology: -16.1%-158.9% Q1'26: 0.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+27.3% Q1'26: +34.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×0.00× Q1'26: 0.00× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Jun 2022 actual |
Jun 2023 actual |
Jun 2025 actual |
Jun 2026 1 Rev. Ana. 1 EPS Ana. |
Jun 2027 1 Rev. Ana. 1 EPS Ana. |
Jun 2028 1 EPS Ana. |
|---|---|---|---|---|---|---|
| Revenue |
—
est: 14.50M (-100.0%)
|
—
est: 26.39M (-100.0%)
|
—
|
3.00M
3.00M – 3.00M
|
7.00M
7.00M – 7.00M
+133.3% YoY
|
—
— – —
-100.0% YoY
|
| EBITDA |
-7.38M
|
-7.84M
|
-8.72M
|
—
— – —
|
—
— – —
|
—
— – —
|
| EBIT |
-8.10M
|
-8.59M
|
-9.47M
|
—
— – —
|
—
— – —
|
—
— – —
|
| Net Income |
-8.11M
est: -11.79M (+31.2%)
|
-8.59M
est: -6.50M (-32.1%)
|
-9.47M
est: -11.04M (+14.2%)
|
-5.29M
-5.29M – -5.29M
+52.1% YoY
|
-5.29M
-5.29M – -5.29M
+0.0% YoY
|
-5.29M
-5.29M – -5.29M
+0.0% YoY
|
| SGA |
2.33M
|
2.55M
|
4.04M
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
-0.70
est: -0.78 (+10.3%)
|
-0.74
est: -0.43 (-72.1%)
|
-0.63
est: -0.73 (+13.7%)
|
-0.35
-0.35 – -0.35
+52.1% YoY
|
-0.35
-0.35 – -0.35
+0.0% YoY
|
-0.35
-0.35 – -0.35
+0.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-14 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-13 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-12 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-11 | C | 2/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-08 | C | 2/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-07 | C | 2/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-06 | C | 2/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-05 | C | 2/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-04 | C | 2/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-01 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-30 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-29 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-28 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-27 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-24 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-23 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-22 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-21 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-20 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-17 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-16 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
Owner Earnings
Owner's Earnings (history)
Owner's Earnings history not available.
Owner alignment
Owner's Earnings TTM
—
OE per share TTM
—
Owner's Yield
—
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
—
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
48
Total invested
1.73M
Insider transactions (90d)
0
Beneficial owners (>5%)
11
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Milton Boniuk, M.D. | 10.46M | 15.20% | 9.83M | 628.6K | 9.83M | 628.6K | IN | United States | 2018-10-12 | ↗ |
| 2 | Growth GP, LLC | 750.0K | 7.20% | — | 750.0K | — | — | OO | Delaware, United States of America | 2020-07-20 | ↗ |
| 3 | Empery Asset Master, Ltd. | 381.7K | 5.67% | — | 381.7K | — | — | CO | Cayman Islands | 2020-01-27 | ↗ |
| 4 | Altium Capital Management, LP | — | 0.00% | — | — | — | — | IA, PN | Delaware, United States of America | 2021-02-12 | ↗ |
| 5 | Altium Growth Fund, LP | — | 0.00% | — | — | — | — | PN | Delaware, United States of America | 2021-02-12 | ↗ |
| 6 | Altium Growth GP, LLC | — | 0.00% | — | — | — | — | OO | Delaware, United States of America | 2021-02-12 | ↗ |
| 7 | CVI Investments, Inc. | — | 0.00% | — | — | — | — | CO | Cayman Islands | 2021-02-16 | ↗ |
| 8 | Empery Asset Management, LP | — | 0.00% | — | — | — | — | PN | Delaware | 2021-01-26 | ↗ |
| 9 | Heights Capital Management, Inc. | — | 0.00% | — | — | — | — | CO | Cayman Islands | 2021-02-16 | ↗ |
| 10 | Martin D. Hoe | — | 0.00% | — | — | — | — | IN | Delaware | 2021-01-26 | ↗ |
| 11 | Ryan M. Lane | — | 0.00% | — | — | — | — | IN | Delaware | 2021-01-26 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
48
+3 vs prev Q
New positions
14
Closed positions
9
Increased
24
Reduced
3
Put/Call ratio
0.00
Calls held
35.9K
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | ARMISTICE CAPITAL, LLC | 1.37M +1.4M (+100.0%) | 1.55M +1.5M (+100.0%) | 8.01% +8.008 pp | 0.02% +0.018 pp | USD1.13 +0.0% | 1 qtrs NEW |
| 2 | VANGUARD GROUP INC | 605.6K +— (+0.0%) | 684.3K -181.7K (-21.0%) | 3.05% -0.955 pp | 0.00% +0.000 pp | USD3.61 -68.7% | 26 qtrs — |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 174.4K +14.9K (+9.4%) | 197.1K -31.0K (-13.6%) | 0.88% -0.176 pp | 0.00% +0.000 pp | USD3.39 -66.7% | 24 qtrs — |
| 4 | RENAISSANCE TECHNOLOGIES LLC | 173.4K -37.1K (-17.6%) | 195.9K -105.1K (-34.9%) | 0.87% -0.519 pp | 0.00% 0.000 pp | USD1.75 -35.4% | 17 qtrs — |
| 5 | BLACKROCK, INC. | 158.8K +— (+0.0%) | 179.4K -47.6K (-21.0%) | 0.80% -0.250 pp | 0.00% +0.000 pp | USD1.50 -24.7% | 6 qtrs — |
| 6 | JANE STREET GROUP, LLC | 124.1K +124.1K (+100.0%) | 140.2K +140.2K (+100.0%) | 0.63% +0.625 pp | 0.00% +0.000 pp | USD1.13 +0.0% | 1 qtrs NEW |
| 7 | MILLER FINANCIAL SERVICES LLC | 72.0K +72.0K (+100.0%) | 81.4K +81.4K (+100.0%) | 0.42% +0.422 pp | 0.10% +0.095 pp | USD1.13 +0.0% | 1 qtrs NEW |
| 8 | STATE STREET CORP | 54.2K +12.3K (+29.4%) | 61.3K +1.3K (+2.2%) | 0.27% -0.004 pp | 0.00% +0.000 pp | USD3.77 -70.0% | 19 qtrs — |
| 9 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 36.0K +— (+0.0%) | 40.7K -10.8K (-21.0%) | 0.18% -0.057 pp | 0.00% 0.000 pp | USD5.37 -79.0% | 24 qtrs — |
| 10 | UBS GROUP AG | 32.5K +5.8K (+21.7%) | 36.7K -1.5K (-3.9%) | 0.16% -0.013 pp | 0.00% +0.000 pp | USD1.35 -16.3% | 10 qtrs — |
| 11 | CITADEL ADVISORS LLC | 25.2K -12.1K (-32.4%) | 28.5K -24.9K (-46.6%) | 0.13% -0.120 pp | 0.00% +0.000 pp | USD1.35 -16.3% | 22 qtrs — |
| 12 | NORTHERN TRUST CORP | 24.3K +— (+0.0%) | 27.4K -7.3K (-21.0%) | 0.14% -0.019 pp | 0.00% +0.000 pp | USD4.68 -75.9% | 23 qtrs — |
| 13 | MOSS ADAMS WEALTH ADVISORS LLC | 20.0K +3.0K (+17.6%) | 22.6K -1.7K (-7.0%) | 0.12% +0.005 pp | 0.00% 0.000 pp | USD1.70 -33.5% | 10 qtrs — |
| 14 | XTX TOPCO LTD | 18.9K +8.1K (+75.3%) | 21.3K +5.9K (+38.5%) | 0.10% +0.024 pp | 0.00% 0.000 pp | USD1.15 -1.7% | 4 qtrs — |
| 15 | MORGAN STANLEY | 18.7K +16.7K (+857.9%) | 21.1K +18.3K (+657.0%) | 0.09% +0.081 pp | 0.00% +0.000 pp | USD1.16 -2.6% | 26 qtrs — |
| 16 | TWO SIGMA SECURITIES, LLC | 17.2K +17.2K (+100.0%) | 19.4K +19.4K (+100.0%) | 0.09% +0.087 pp | 0.00% +0.003 pp | USD1.13 +0.0% | 1 qtrs NEW |
| 17 | WHARTON BUSINESS GROUP, LLC | 15.7K +— (+0.0%) | 17.8K -4.7K (-21.0%) | 0.09% -0.012 pp | 0.00% 0.000 pp | USD3.72 -69.6% | 26 qtrs — |
| 18 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 13.1K +13.1K (+100.0%) | 14.8K +14.8K (+100.0%) | 0.07% +0.066 pp | 0.00% +0.000 pp | USD1.13 +0.0% | 4 qtrs — |
| 19 | FOUNDATIONS INVESTMENT ADVISORS, LLC | 10.0K +— (+0.0%) | 11.3K -3.0K (-21.0%) | 0.06% -0.008 pp | 0.00% 0.000 pp | USD1.40 -19.3% | 3 qtrs — |
| 20 | TRUE PRIVATE WEALTH ADVISORS | 10.0K +— (+0.0%) | 11.3K -3.0K (-21.0%) | 0.06% -0.008 pp | 0.00% 0.000 pp | USD1.43 -21.0% | 2 qtrs — |
| 21 | BANKPLUS TRUST DEPARTMENT | 7.0K +— (+0.0%) | 7.9K -2.1K (-21.0%) | 0.04% -0.005 pp | 0.00% -0.001 pp | USD1.43 -21.0% | 5 qtrs — |
| 22 | ADVISOR GROUP HOLDINGS, INC. | 4.8K +119.0 (+2.6%) | 5.4K -1.1K (-17.4%) | 0.02% -0.007 pp | 0.00% +0.000 pp | USD1.54 -26.6% | 14 qtrs — |
| 23 | — | 4.5K +4.5K (+100.0%) | 5.1K +5.1K (+100.0%) | 0.02% +0.023 pp | 0.00% +0.000 pp | USD1.13 +0.0% | 1 qtrs NEW |
| 24 | TOWER RESEARCH CAPITAL LLC (TRC) | 4.4K +3.5K (+429.6%) | 4.9K +3.7K (+318.5%) | 0.02% +0.017 pp | 0.00% +0.000 pp | USD1.19 -5.0% | 8 qtrs — |
| 25 | NBC SECURITIES, INC. | 3.4K +— (+0.0%) | 3.8K -1.0K (-21.0%) | 0.02% -0.005 pp | 0.00% 0.000 pp | USD1.17 -3.4% | 10 qtrs — |
| 26 | JONES FINANCIAL COMPANIES LLLP | 3.0K +3.0K (+100.0%) | 3.4K +3.4K (+100.0%) | 0.02% +0.018 pp | 0.00% +0.000 pp | USD1.13 +0.0% | 1 qtrs NEW |
| 27 | JPMORGAN CHASE & CO | 3.0K +3.0K (+8,723.5%) | 3.4K +3.3K (+6,818.4%) | 0.02% +0.017 pp | 0.00% +0.000 pp | USD1.13 +0.0% | 4 qtrs — |
| 28 | SIMPLEX TRADING, LLC | 2.8K +693.0 (+32.8%) | 3.2K +167.0 (+5.6%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD1.36 -16.9% | 2 qtrs — |
| 29 | CURIO WEALTH, LLC | 2.0K +2.0K (+100.0%) | 2.4K +2.4K (+100.0%) | 0.01% +0.012 pp | 0.00% +0.001 pp | USD1.13 +0.0% | 1 qtrs NEW |
| 30 | ASSET DEDICATION, LLC | 1.5K +— (+0.0%) | 1.6K -435.0 (-21.0%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD1.73 -34.7% | 14 qtrs — |
| 31 | GROUP ONE TRADING, L.P. | 1.0K +— (+0.0%) | 1.2K -307.0 (-21.0%) | 0.01% -0.002 pp | 0.00% +0.000 pp | USD1.43 -21.0% | 5 qtrs — |
| 32 | ACTIVEST WEALTH MANAGEMENT | 1.0K +— (+0.0%) | 1.1K -300.0 (-21.0%) | 0.01% -0.001 pp | 0.00% 0.000 pp | USD1.85 -38.9% | 7 qtrs — |
| 33 | SITTNER & NELSON, LLC | 1.0K +1.0K (+100.0%) | 880.00 +880.0 (+100.0%) | 0.01% +0.006 pp | 0.00% +0.000 pp | USD1.13 +0.0% | 1 qtrs NEW |
| 34 | BERNARD WEALTH MANAGEMENT CORP. | 500.00 +— (+0.0%) | 565.00 -150.0 (-21.0%) | 0.00% 0.000 pp | 0.00% 0.000 pp | USD1.43 -21.0% | 5 qtrs — |
| 35 | CLEARSTEAD ADVISORS, LLC | 293.00 +— (+0.0%) | 332.00 -87.0 (-20.8%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD1.88 -39.9% | 15 qtrs — |
| 36 | BANK OF AMERICA CORP /DE/ | 269.00 +23.0 (+9.3%) | 304.00 -48.0 (-13.6%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD1.40 -19.3% | 13 qtrs — |
| 37 | ATLANTIC UNION BANKSHARES CORP | 265.00 +— (+0.0%) | 300.00 -79.0 (-20.8%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD1.40 -19.3% | 3 qtrs — |
| 38 | TD WATERHOUSE CANADA INC. | 260.00 +— (+0.0%) | 289.00 -87.0 (-23.1%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD1.85 -38.9% | 17 qtrs — |
| 39 | DECISIONPOINT FINANCIAL, LLC | 50.00 +50.0 (+100.0%) | 57.00 +57.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.12 +0.9% | 1 qtrs NEW |
| 40 | NATIONAL BANK OF CANADA /FI/ | 50.00 +50.0 (+100.0%) | 56.00 +56.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.12 +0.9% | 1 qtrs NEW |
| 41 | US BANCORP \DE\ | 43.00 +— (+0.0%) | 49.00 -12.0 (-19.7%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.09 +3.7% | 13 qtrs — |
| 42 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 35.00 +35.0 (+100.0%) | 40.00 +40.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.11 +1.8% | 1 qtrs NEW |
| 43 | CITIGROUP INC | 1.00 -5.3K (-100.0%) | 1.00 -7.5K (-100.0%) | 0.00% -0.035 pp | 0.00% +0.000 pp | USD1.00 +13.0% | 2 qtrs — |
| 44 | SBI SECURITIES CO., LTD. | — -300.0 (-100.0%) | — -429.0 (-100.0%) | 0.00% -0.002 pp | 0.00% +0.000 pp | USD— | 3 qtrs SOLD |
| 45 | ADVISORY SERVICES NETWORK, LLC | — -3.0K (-100.0%) | — -4.3K (-100.0%) | 0.00% -0.020 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
| 46 | FMR LLC | — -36.0 (-100.0%) | — -51.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 5 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 11 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard Extended Market ETF VXF | 0.00% | 426.8K | 0.05% |
| 2 | Vanguard U.S. Total Market Shares Index ETF VTS.AX | 0.00% | 2.3K | 0.03% |
| 3 | Vanguard U.S. Total Market Index ETF VUN.TO | 0.00% | 6.3K | 0.17% |
| 4 | Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO | 0.00% | 466.44 | 0.17% |
| 5 | Vanguard Total Stock Market ETF VTI | 0.00% | 1.08M | 0.03% |
| 6 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 2.4K | 0.22% |
| 7 | Vanguard Growth ETF Portfolio VGRO.TO | 0.00% | 1.3K | 0.22% |
| 8 | Vanguard Balanced ETF Portfolio VBAL.TO | 0.00% | 519.92 | 0.22% |
| 9 | Vanguard Conservative ETF Portfolio VCNS.TO | 0.00% | 57.31 | 0.22% |
| 10 | Vanguard Conservative Income ETF Portfolio VCIP.TO | 0.00% | 8.06 | 0.22% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Ratio by volume
0.00
Bearish
Buys
0
Sells
1
Shares acquired
—
Shares disposed
94.5K
Cash buys
—
Cash sales
—
Net activity
-94,471
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-08 | Diwan Anil | Director | G-Gift | D | Common Stock, par value $0.001 per share | 94,471 | 0.00 | — | 0 | — | ↗ |
| 2020-02-07 | Jawadakar Makarand | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-06-02 | Day Mark D. | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2018-05-21 | BONIUK MILTON | 10% Owner | M-Exempt | A | Common Stock, par value $0.001 per share | 5,500,000 | 1.00 | 5.50M | 6,862,648 | — | ↗ |
| 2018-05-01 | Seymour Eugene | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2017-07-11 | BONIUK MILTON | 10% Owner | A-Award | A | Common Stock, par value $0.001 per share | 120,744 | 1.38 | 166.6K | 1,362,648 | — | ↗ |
| 2017-05-04 | BONIUK MILTON | 10% Owner | A-Award | A | Common Stock, par value $0.001 per share | 149,478 | 1.11 | 165.9K | 1,241,904 | — | ↗ |
| 2017-02-21 | Stephenson Fournier, PLLC | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2017-02-21 | BONIUK MILTON | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2017-02-01 | BONIUK MILTON | Director | J-Other | D | Common Stock, par value $0.001 per share | 605,474 | 0.00 | — | 0 | — | ↗ |
| 2016-05-19 | BONIUK MILTON | Director | A-Award | A | Common Stock, par value $0.001 per share | 25,000 | 1.50 | 37.5K | 1,240,063 | — | ↗ |
| 2016-05-12 | BONIUK MILTON | Director | A-Award | A | Common Stock, par value $0.001 per share | 25,000 | 1.50 | 37.5K | 1,215,063 | — | ↗ |
| 2016-05-04 | BONIUK MILTON | Director | A-Award | A | Common Stock, par value $0.001 per share | 14,991 | 1.68 | 25.2K | 1,190,063 | — | ↗ |
| 2016-04-29 | BONIUK MILTON | Director | A-Award | A | Common Stock, par value $0.001 per share | 2,900 | 1.68 | 4.9K | 1,177,972 | — | ↗ |
| 2016-04-28 | BONIUK MILTON | Director | A-Award | A | Common Stock, par value $0.001 per share | 7,109 | 1.68 | 11.9K | 1,175,072 | — | ↗ |
| 2016-04-27 | BONIUK MILTON | Director | A-Award | A | Common Stock, par value $0.001 per share | 25,000 | 1.78 | 44.5K | 1,167,963 | — | ↗ |
| 2016-02-18 | BONIUK MILTON | Director | A-Award | A | Common Stock, par value $0.001 per share | 9,000 | 1.70 | 15.3K | 1,142,963 | — | ↗ |
| 2016-02-12 | BONIUK MILTON | Director | A-Award | A | Common Stock, par value $0.001 per share | 141,844 | 1.18 | 167.4K | 309,844 | — | ↗ |
| 2016-02-10 | BONIUK MILTON | Director | A-Award | A | Common Stock, par value $0.001 per share | 9,000 | 1.36 | 12.2K | 168,000 | — | ↗ |
| 2016-02-08 | BONIUK MILTON | Director | A-Award | A | Common Stock, par value $0.001 per share | 9,000 | 1.40 | 12.6K | 159,000 | — | ↗ |
| 2015-11-11 | BONIUK MILTON | Director | P-Purchase | A | Common Stock, par value $0.001 per share | 25,000 | 1.20 | 30.0K | 150,000 | — | ↗ |
| 2015-10-22 | BONIUK MILTON | Director | P-Purchase | A | Common Stock, par value $0.001 per share | 14,640 | 1.30 | 19.0K | 125,000 | — | ↗ |
| 2015-10-21 | BONIUK MILTON | Director | P-Purchase | A | Common Stock, par value $0.001 per share | 5,202 | 1.30 | 6.8K | 110,360 | — | ↗ |
| 2015-10-19 | BONIUK MILTON | Director | P-Purchase | A | Common Stock, par value $0.001 per share | 2,958 | 1.30 | 3.8K | 105,158 | — | ↗ |
| 2015-10-15 | BONIUK MILTON | Director | P-Purchase | A | Common Stock, par value $0.001 per share | 2,200 | 1.30 | 2.9K | 102,200 | — | ↗ |
| 2015-09-22 | Seymour Eugene | Director / Officer | M-Exempt | A | Common Stock, par value $0.001 per share | 104,384 | 0.35 | 36.5K | 1,287,286 | — | ↗ |
| 2015-09-22 | Diwan Anil | Director / Officer / 10% Owner | M-Exempt | D | Common Stock Options | 285,715 | 0.35 | 100.0K | 0 | — | ↗ |
| 2015-09-18 | Seymour Eugene | Director / Officer | M-Exempt | D | Common Stock Options | 142,856 | 0.35 | 50.0K | 0 | — | ↗ |
| 2015-09-11 | BONIUK MILTON | Director | P-Purchase | A | Common Stock, par value $0.001 per share | 50,000 | 1.02 | 51.0K | 100,000 | — | ↗ |
| 2015-08-26 | BONIUK MILTON | Director | P-Purchase | A | Common Stock, par value $0.001 | 50,000 | 1.05 | 52.5K | 1,705,391 | — | ↗ |
| 2015-08-21 | BONIUK MILTON | Director | P-Purchase | A | Common Stock, par value $0.001 | 29,853 | 1.25 | 37.3K | 1,655,391 | — | ↗ |
| 2015-08-20 | BONIUK MILTON | Director | P-Purchase | A | Common Stock, par value $0.001 | 2,662 | 1.25 | 3.3K | 1,625,538 | — | ↗ |
| 2015-08-19 | BONIUK MILTON | Director | P-Purchase | A | Common Stock, par value $0.001 | 300 | 1.25 | 375.00 | 1,622,876 | — | ↗ |
| 2015-08-18 | BONIUK MILTON | Director | P-Purchase | A | Common Stock, par value $0.001 | 2,547 | 1.25 | 3.2K | 1,622,576 | — | ↗ |
| 2015-08-17 | BONIUK MILTON | Director | P-Purchase | A | Common Stock, par value $0.001 | 5,244 | 1.25 | 6.6K | 1,620,029 | — | ↗ |
| 2015-08-14 | BONIUK MILTON | Director | P-Purchase | A | Common Stock, par value $0.001 | 8,594 | 1.25 | 10.7K | 1,614,785 | — | ↗ |
| 2015-08-13 | BONIUK MILTON | Director | P-Purchase | A | Common Stock, par value $0.001 | 800 | 1.25 | 1.0K | 1,606,191 | — | ↗ |
| 2015-07-08 | BONIUK MILTON | Director | P-Purchase | A | Common Stock, par value $0.001 | 50,000 | 1.58 | 79.0K | 50,000 | — | ↗ |
| 2015-06-22 | BONIUK MILTON | Director | P-Purchase | A | Common Stock, par value $0.001 | 43,472 | 1.90 | 82.6K | 1,605,391 | — | ↗ |
| 2015-06-19 | BONIUK MILTON | Director | P-Purchase | A | Common Stock, par value $0.001 | 6,528 | 1.90 | 12.4K | 1,561,919 | — | ↗ |
| 2015-06-16 | BONIUK MILTON | Director | P-Purchase | A | Common Stock, par value $0.001 | 42,247 | 1.99 | 84.1K | 1,555,391 | — | ↗ |
| 2015-06-15 | BONIUK MILTON | Director | P-Purchase | A | Common Stock, par value $0.001 | 7,753 | 2.00 | 15.5K | 1,515,144 | — | ↗ |
| 2015-05-20 | BONIUK MILTON | Director | P-Purchase | A | Common Stock, par value $0.001 | 25,000 | 1.60 | 40.0K | 1,505,391 | — | ↗ |
| 2015-05-19 | BONIUK MILTON | Director | P-Purchase | A | Common Stock, par value $0.001 | 25,000 | 1.60 | 40.0K | 1,480,391 | — | ↗ |
| 2015-05-08 | BONIUK MILTON | Director | P-Purchase | A | Common Stock, par value $0.001 | 25,000 | 1.75 | 43.8K | 1,455,391 | — | ↗ |
| 2015-03-06 | BONIUK MILTON | Director | P-Purchase | A | Common Stock, par value $0.001 | 190,477 | 2.63 | 501.0K | 942,859 | — | ↗ |
| 2015-01-13 | Diwan Anil | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 5,000 | 2.75 | 13.8K | 2,074,918 | — | ↗ |
| 2015-01-12 | Diwan Anil | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 7,392 | 2.71 | 20.0K | 2,082,310 | — | ↗ |
| 2015-01-09 | Diwan Anil | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 4,000 | 2.58 | 10.3K | 2,048,918 | — | ↗ |
| 2015-01-06 | BONIUK MILTON | Director | P-Purchase | A | Common Stock, par value $0.001 | 25,000 | 2.60 | 65.0K | 1,430,391 | — | ↗ |
| 2014-12-15 | BONIUK MILTON | Director | P-Purchase | A | Common Stock, par value $0.001 | 25,000 | 2.70 | 67.5K | 1,405,391 | — | ↗ |
| 2014-12-09 | BONIUK MILTON | Director | P-Purchase | A | Common Stock, par value $0.001 | 25,000 | 3.00 | 75.0K | 1,380,391 | — | ↗ |
| 2014-12-05 | BONIUK MILTON | Director | P-Purchase | A | Common Stock, par value $0.001 | 12,500 | 3.10 | 38.8K | 1,355,391 | — | ↗ |
| 2014-12-04 | BONIUK MILTON | Director | P-Purchase | A | Common Stock, par value $0.001 | 12,500 | 3.10 | 38.8K | 1,342,891 | — | ↗ |
| 2014-11-07 | BONIUK MILTON | Director | P-Purchase | A | Common Stock, par value $0.001 | 190,477 | 0.00 | — | 380,954 | — | ↗ |
| 2014-10-01 | BONIUK MILTON | Director | P-Purchase | A | Common Stock, par value $0.001 | 1,200 | 3.10 | 3.7K | 740,463 | — | ↗ |
| 2014-09-30 | BONIUK MILTON | Director | P-Purchase | A | Common Stock, par value $0.001 | 11,692 | 3.15 | 36.9K | 739,263 | — | ↗ |
| 2014-09-29 | BONIUK MILTON | Director | P-Purchase | A | Common Stock, par value $0.001 | 15,841 | 3.20 | 50.7K | 677,921 | — | ↗ |
| 2014-09-26 | BONIUK MILTON | Director | P-Purchase | A | Common Stock, par value $0.001 | 3,167 | 3.20 | 10.1K | 662,130 | — | ↗ |
| 2014-08-25 | VYAS MEETA | Officer | P-Purchase | A | Common Stock, par value $0.001 | 21,429 | 3.50 | 75.0K | 147,021 | — | ↗ |
| 2014-08-25 | Diwan Anil | Director / Officer / 10% Owner | P-Purchase | A | Common Stock, par value $0.001 per share | 28,571 | 3.50 | 100.0K | 2,044,918 | — | ↗ |
| 2014-07-17 | BONIUK MILTON | Director | P-Purchase | A | Common Stock, par value $0.001 | 28,572 | 3.50 | 100.0K | 658,963 | — | ↗ |
| 2014-07-11 | BONIUK MILTON | Director | A-Award | A | Series A Convertible Preferred Stock | 187,000 | 0.00 | — | 187,000 | — | ↗ |
| 2014-07-02 | BONIUK MILTON | Director | A-Award | A | 10% Coupon Series C Convertible Debenture | 1 | 5.25 | 5.25 | 1 | — | ↗ |
| 2014-02-20 | Diwan Anil | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 15,000 | 3.80 | 57.0K | 2,016,347 | — | ↗ |
| 2014-02-18 | Diwan Anil | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 5,000 | 3.52 | 17.6K | 2,001,347 | — | ↗ |
| 2013-10-21 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 142,000 | 5.29 | 751.2K | 1,824,286 | — | ↗ |
| 2013-09-12 | BONIUK MILTON | Director | P-Purchase | A | Common Stock, par value $0.001 per share | 571,428 | 3.50 | 2.00M | 658,571 | — | ↗ |
| 2013-09-11 | BONIUK MILTON | Director | A-Award | A | Common Stock Warrants | 285,714 | 5.25 | 1.50M | 285,714 | — | ↗ |
| 2013-06-24 | KULKARNI MUKUND S | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2013-05-28 | BONIUK MILTON | Director | — | I | Unsecured 8% Coupon Series B Convertible Debenture | 0 | 1.00 | — | 0 | — | ↗ |
| 2013-05-13 | VYAS MEETA | Officer | — | I | Warrants to purchase Common Stock | 75,000 | 1.00 | 75.0K | 0 | — | ↗ |
| 2013-03-06 | Seymour Eugene | Director / Officer | P-Purchase | A | Common Stock | 25,000 | 0.69 | 17.3K | 6,025,000 | — | ↗ |
| 2013-03-04 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | A | Common Stock | 147,000 | 0.50 | 73.5K | 6,379,200 | — | ↗ |
| 2013-03-01 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | A | Common Stock | 100,000 | 0.49 | 49.0K | 6,232,200 | — | ↗ |
| 2013-02-28 | Diwan Anil | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 250,000 | 0.49 | 122.5K | 6,132,200 | — | ↗ |
| 2013-01-30 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 39,000 | 0.50 | 19.5K | 33,321,000 | — | ↗ |
| 2011-10-17 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 39,375 | 0.78 | 30.7K | 6,717,045 | — | ↗ |
| 2011-10-14 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 18,000 | 0.83 | 14.9K | 6,756,420 | — | ↗ |
| 2011-10-13 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 26,000 | 0.85 | 22.1K | 6,774,420 | — | ↗ |
| 2011-10-12 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 12,000 | 0.86 | 10.3K | 6,800,420 | — | ↗ |
| 2011-10-11 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 15,000 | 0.87 | 13.1K | 6,812,420 | — | ↗ |
| 2011-10-10 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 5,000 | 0.89 | 4.5K | 6,827,420 | — | ↗ |
| 2011-10-07 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 17,000 | 0.96 | 16.3K | 6,832,420 | — | ↗ |
| 2011-10-06 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 11,000 | 0.99 | 10.9K | 6,849,420 | — | ↗ |
| 2011-10-05 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 25,000 | 0.96 | 24.0K | 6,860,420 | — | ↗ |
| 2011-10-04 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 35,000 | 0.96 | 33.6K | 6,885,420 | — | ↗ |
| 2011-09-23 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 9,930 | 1.05 | 10.4K | 6,920,420 | — | ↗ |
| 2011-09-22 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 10,000 | 109.00 | 1.09M | 6,930,350 | — | ↗ |
| 2011-09-21 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 15,000 | 1.11 | 16.7K | 6,940,350 | — | ↗ |
| 2011-09-20 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 5,000 | 1.12 | 5.6K | 6,955,350 | — | ↗ |
| 2011-09-16 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 16,600 | 1.11 | 18.4K | 6,960,350 | — | ↗ |
| 2011-09-15 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 20,500 | 1.12 | 23.0K | 6,986,950 | — | ↗ |
| 2011-09-14 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 5,000 | 1.13 | 5.7K | 7,007,450 | — | ↗ |
| 2011-09-13 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 7,500 | 1.12 | 8.4K | 7,012,450 | — | ↗ |
| 2011-09-12 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 15,000 | 1.07 | 16.1K | 7,019,950 | — | ↗ |
| 2011-09-08 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 46,000 | 1.10 | 50.6K | 7,034,950 | — | ↗ |
| 2011-09-07 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 30,080 | 1.07 | 32.2K | 7,080,950 | — | ↗ |
| 2011-09-06 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 15,000 | 1.06 | 15.8K | 7,111,030 | — | ↗ |
| 2011-09-02 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 5,000 | 1.07 | 5.4K | 7,121,030 | — | ↗ |
| 2011-09-01 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 11,850 | 1.09 | 12.9K | 7,126,030 | — | ↗ |
| 2011-08-30 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 12,625 | 1.08 | 13.6K | 7,148,580 | — | ↗ |
| 2011-08-29 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 13,200 | 1.11 | 14.7K | 7,161,205 | — | ↗ |
| 2011-08-26 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 5,000 | 1.10 | 5.5K | 7,174,405 | — | ↗ |
| 2011-08-25 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 10,000 | 1.11 | 11.1K | 7,179,405 | — | ↗ |
| 2011-08-24 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 10,000 | 1.15 | 11.5K | 7,189,405 | — | ↗ |
| 2011-08-23 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 16,400 | 1.16 | 19.0K | 7,199,405 | — | ↗ |
| 2011-08-22 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 5,000 | 1.17 | 5.9K | 7,215,805 | — | ↗ |
| 2011-08-19 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 14,500 | 1.16 | 16.8K | 7,220,805 | — | ↗ |
| 2011-08-18 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 5,000 | 1.18 | 5.9K | 7,235,305 | — | ↗ |
| 2011-08-17 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 9,200 | 1.19 | 10.9K | 7,240,305 | — | ↗ |
| 2011-08-16 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 18,375 | 1.19 | 21.9K | 7,249,505 | — | ↗ |
| 2011-08-15 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 27,000 | 1.20 | 32.4K | 7,267,880 | — | ↗ |
| 2011-08-12 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 5,000 | 1.06 | 5.3K | 7,294,880 | — | ↗ |
| 2011-08-11 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 16,000 | 1.09 | 17.4K | 7,299,880 | — | ↗ |
| 2011-08-10 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 24,600 | 1.04 | 25.6K | 7,315,880 | — | ↗ |
| 2011-08-09 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 44,000 | 1.05 | 46.2K | 7,340,480 | — | ↗ |
| 2011-08-08 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 60,000 | 1.03 | 61.8K | 7,384,480 | — | ↗ |
| 2011-08-05 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 22,500 | 1.14 | 25.7K | 7,444,480 | — | ↗ |
| 2011-08-04 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 21,900 | 1.17 | 25.6K | 7,466,980 | — | ↗ |
| 2011-08-03 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 38,000 | 1.22 | 46.4K | 7,488,880 | — | ↗ |
| 2011-08-01 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 7,500 | 1.18 | 8.9K | 7,526,880 | — | ↗ |
| 2011-07-29 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 7,500 | 1.16 | 8.7K | 7,534,380 | — | ↗ |
| 2011-07-25 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 7,500 | 1.23 | 9.2K | 7,546,880 | — | ↗ |
| 2011-07-22 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 5,000 | 1.22 | 6.1K | 7,541,880 | — | ↗ |
| 2011-07-21 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 5,000 | 1.22 | 6.1K | 7,560,380 | — | ↗ |
| 2011-07-20 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 5,000 | 1.22 | 6.1K | 7,565,380 | — | ↗ |
| 2011-07-19 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 11,675 | 1.23 | 14.4K | 7,570,380 | — | ↗ |
| 2011-07-18 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 7,500 | 1.27 | 9.5K | 7,582,055 | — | ↗ |
| 2011-07-15 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 5,000 | 1.25 | 6.3K | 7,589,555 | — | ↗ |
| 2011-07-14 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 5,000 | 1.25 | 6.3K | 7,594,555 | — | ↗ |
| 2011-07-13 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 5,000 | 1.28 | 6.4K | 7,599,555 | — | ↗ |
| 2011-07-12 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 7,600 | 1.27 | 9.7K | 7,604,555 | — | ↗ |
| 2011-07-11 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 10,000 | 1.31 | 13.1K | 7,612,155 | — | ↗ |
| 2011-07-08 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 5,000 | 1.35 | 6.8K | 7,622,155 | — | ↗ |
| 2011-07-07 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 16,000 | 1.37 | 21.9K | 7,627,155 | — | ↗ |
| 2011-07-06 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 29,500 | 1.44 | 42.5K | 7,643,155 | — | ↗ |
| 2011-07-05 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 57,000 | 1.40 | 79.8K | 7,672,655 | — | ↗ |
| 2011-07-01 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 5,000 | 1.20 | 6.0K | 7,729,655 | — | ↗ |
| 2011-06-30 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 5,000 | 1.22 | 6.1K | 7,734,655 | — | ↗ |
| 2011-06-29 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 6,500 | 1.12 | 7.3K | 7,739,655 | — | ↗ |
| 2011-06-28 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 12,500 | 1.19 | 14.9K | 7,746,155 | — | ↗ |
| 2011-06-27 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 40,000 | 1.14 | 45.7K | 7,758,655 | — | ↗ |
| 2011-06-23 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 7,000 | 1.27 | 8.9K | 7,798,655 | — | ↗ |
| 2011-06-22 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 25,695 | 1.28 | 32.9K | 7,805,655 | — | ↗ |
| 2011-06-21 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 10,750 | 1.33 | 14.3K | 7,831,350 | — | ↗ |
| 2011-06-20 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 3,000 | 1.36 | 4.1K | 7,842,100 | — | ↗ |
| 2011-06-17 | Diwan Anil | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 5,000 | 1.37 | 6.8K | 7,853,100 | — | ↗ |
| 2011-06-16 | Diwan Anil | Director / Officer / 10% Owner | G-Gift | D | Common Stock | 13,000 | 1.38 | 17.9K | 7,858,100 | — | ↗ |
| 2011-06-15 | Diwan Anil | Director / Officer / 10% Owner | G-Gift | D | Common Stock | 11,100 | 1.38 | 15.3K | 7,871,100 | — | ↗ |
| 2011-02-15 | Diwan Anil | Director / Officer / 10% Owner | G-Gift | D | Common Stock | 2,117,800 | 0.00 | — | 7,882,200 | — | ↗ |
| 2010-11-12 | Seymour Eugene | Director / 10% Owner | G-Gift | D | Common Stock | 2,500,000 | 0.00 | — | 6,000,000 | — | ↗ |
| 2010-06-24 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 353,982 | 0.57 | 200.0K | 33,006,018 | — | ↗ |
| 2009-12-03 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 5,000 | 0.85 | 4.3K | 33,567,955 | — | ↗ |
| 2009-12-02 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 15,000 | 0.88 | 13.2K | 33,572,955 | — | ↗ |
| 2009-12-01 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 15,000 | 0.84 | 12.6K | 33,587,955 | — | ↗ |
| 2009-11-30 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 20,000 | 0.85 | 17.0K | 33,602,955 | — | ↗ |
| 2009-11-25 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 34,000 | 0.89 | 30.3K | 33,622,955 | — | ↗ |
| 2009-11-24 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 30,045 | 0.84 | 25.2K | 33,656,955 | — | ↗ |
| 2009-11-23 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 10,000 | 0.93 | 9.3K | 33,687,000 | — | ↗ |
| 2009-11-20 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 42,500 | 0.89 | 37.8K | 33,697,000 | — | ↗ |
| 2009-11-19 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 40,000 | 0.89 | 35.6K | 33,739,500 | — | ↗ |
| 2009-11-18 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 10,000 | 0.88 | 8.8K | 33,779,500 | — | ↗ |
| 2009-11-17 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 10,000 | 0.88 | 8.8K | 33,789,500 | — | ↗ |
| 2009-11-16 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 30,000 | 0.87 | 26.1K | 33,799,500 | — | ↗ |
| 2009-11-13 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 10,000 | 0.86 | 8.6K | 33,829,500 | — | ↗ |
| 2009-11-12 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 20,000 | 0.86 | 17.2K | 33,839,500 | — | ↗ |
| 2009-11-11 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 20,000 | 0.85 | 17.0K | 33,859,500 | — | ↗ |
| 2009-11-10 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 20,000 | 0.82 | 16.4K | 33,879,500 | — | ↗ |
| 2009-11-06 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 20,000 | 0.82 | 16.4K | 33,899,500 | — | ↗ |
| 2009-11-05 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 25,000 | 0.83 | 20.8K | 33,929,500 | — | ↗ |
| 2009-11-02 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 10,000 | 0.84 | 8.4K | 33,954,500 | — | ↗ |
| 2009-10-30 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 30,000 | 0.86 | 25.8K | 33,964,500 | — | ↗ |
| 2009-10-29 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 10,000 | 0.89 | 8.9K | 33,994,500 | — | ↗ |
| 2009-10-28 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 49,000 | 0.85 | 41.7K | 34,004,500 | — | ↗ |
| 2009-10-22 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 10,000 | 0.59 | 5.9K | 34,053,500 | — | ↗ |
| 2009-10-21 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 10,000 | 0.60 | 6.0K | 34,063,500 | — | ↗ |
| 2009-10-15 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 20,000 | 0.75 | 15.0K | 34,073,500 | — | ↗ |
| 2009-10-13 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 10,000 | 0.77 | 7.7K | 34,093,500 | — | ↗ |
| 2009-09-30 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 10,000 | 0.81 | 8.1K | 34,103,500 | — | ↗ |
| 2009-09-29 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 30,000 | 0.81 | 24.3K | 34,113,500 | — | ↗ |
| 2009-09-28 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 20,000 | 0.85 | 17.0K | 34,143,500 | — | ↗ |
| 2009-09-25 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 17,500 | 0.88 | 15.4K | 34,163,500 | — | ↗ |
| 2009-09-24 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 20,000 | 0.86 | 17.2K | 34,181,000 | — | ↗ |
| 2009-09-23 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 10,000 | 0.86 | 8.6K | 34,201,000 | — | ↗ |
| 2009-09-21 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 20,000 | 0.90 | 18.0K | 34,211,000 | — | ↗ |
| 2009-09-18 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 20,000 | 0.90 | 18.0K | 34,231,000 | — | ↗ |
| 2009-09-16 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 17,900 | 0.91 | 16.3K | 34,251,000 | — | ↗ |
| 2009-09-15 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 20,000 | 0.95 | 19.0K | 34,268,900 | — | ↗ |
| 2009-09-14 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 20,000 | 0.97 | 19.4K | 34,288,900 | — | ↗ |
| 2009-09-10 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 30,000 | 0.95 | 28.5K | 34,308,900 | — | ↗ |
| 2009-09-09 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 30,000 | 0.90 | 27.0K | 34,338,900 | — | ↗ |
| 2009-09-08 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 20,000 | 0.89 | 17.8K | 34,368,900 | — | ↗ |
| 2009-09-04 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 20,000 | 0.84 | 16.8K | 34,388,900 | — | ↗ |
| 2009-09-03 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 20,000 | 0.85 | 17.0K | 34,408,900 | — | ↗ |
| 2009-09-01 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 10,000 | 0.88 | 8.8K | 34,428,900 | — | ↗ |
| 2009-08-25 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 10,000 | 0.91 | 9.1K | 34,438,900 | — | ↗ |
| 2009-08-24 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 12,000 | 0.86 | 10.3K | 34,448,900 | — | ↗ |
| 2009-08-14 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 10,000 | 0.87 | 8.7K | 34,460,900 | — | ↗ |
| 2009-08-12 | Theracour Pharma, Inc. | 10% Owner | S-Sale | D | Common Stock | 20,000 | 0.96 | 19.2K | 34,470,900 | — | ↗ |
Executive team
Top executives
Shares Outstanding
17.87M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Anil Diwan CEO, President, Director | 400.0K | — | 49.4K | — | — | — | 449.8K | 10.98% | ↗ |
| 2 | 2025 | Meeta Vyas CFO | 129.6K | — | 6.3K | — | — | — | 133.9K | 4.72% | ↗ |
| 3 | 2024 | Anil Diwan CEO, President, Director | 400.0K | — | 32.5K | — | — | — | 432.5K | 7.51% | ↗ |
| 4 | 2024 | Meeta Vyas CFO | 129.6K | — | 5.9K | — | — | — | 133.5K | 4.42% | ↗ |
| 5 | 2023 | Anil Diwan CEO, President, Director | 400.0K | — | 43.7K | — | — | — | 443.7K | 9.85% | ↗ |
| 6 | 2023 | Meeta Vyas CFO | 129.6K | — | 7.7K | — | — | — | 137.3K | 5.64% | ↗ |
| 7 | 2022 | Anil Diwan CEO, President, Director | 400.0K | — | 109.0K | — | — | — | 509.0K | 21.41% | ↗ |
| 8 | 2022 | Meeta Vyas CFO | 129.6K | — | 18.1K | — | — | — | 147.7K | 12.27% | ↗ |
| 9 | 2021 | Anil Diwan CEO, President, Director | 400.0K | — | 182.6K | — | — | — | 582.6K | 31.34% | ↗ |
| 10 | 2021 | Meeta Vyas CFO | 129.6K | — | 23.5K | — | — | — | 154.5K | 15.24% | ↗ |
| 11 | 2020 | Anil Diwan President, Director | 400.0K | — | 189.0K | — | — | — | 589.0K | 32.09% | ↗ |
| 12 | 2020 | Anil Diwan CEO, President, Director | 400.0K | — | 189.0K | — | — | — | 589.0K | 32.09% | ↗ |
| 13 | 2020 | Meeta Vyas CFO | 129.6K | — | 20.9K | — | — | — | 150.5K | 13.87% | ↗ |
| 14 | 2019 | Anil Diwan President, Director | 400.0K | — | 189.0K | — | — | — | 589.0K | 32.09% | ↗ |
| 15 | 2019 | Anil Diwan CEO, President, Director | 400.0K | — | 189.0K | — | — | — | 589.0K | 32.09% | ↗ |
| 16 | 2019 | Irach Taraporewala Former CEO | 144.8K | 72.0K | 11.9K | — | — | — | 228.7K | 5.21% | ↗ |
| 17 | 2019 | Irach Taraporewala Ex-CEO | 144.8K | 72.0K | 11.9K | 15.0K | — | — | 228.7K | 11.77% | ↗ |
| 18 | 2019 | Meeta Vyas CFO | 129.6K | — | 24.5K | — | — | — | 154.1K | 15.89% | ↗ |
| 19 | 2018 | Eugene Seymour, Former CEO & Director | 631.3K | 118.8K | 121.0K | 250.0K | — | 63.5K | 934.5K | 39.70% | ↗ |
| 20 | 2018 | Anil Diwan President, Director | 397.9K | 75.0K | 267.1K | — | — | — | 740.1K | 36.10% | ↗ |
| 21 | 2018 | Meeta Vyas CFO | 129.6K | — | 75.4K | — | — | — | 205.0K | 36.77% | ↗ |
| 22 | 2017 | Anil Diwan President, Director | 372.9K | 75.0K | 810.3K | — | — | — | 1.26M | 64.40% | ↗ |
| 23 | 2017 | Eugene Seymour, CEO, Director | 372.9K | 75.0K | 297.3K | — | — | — | 745.2K | 39.89% | ↗ |
| 24 | 2017 | Eugene Seymour, Former CEO & Director | 372.9K | 75.0K | 297.3K | — | — | — | 745.2K | 39.89% | ↗ |
| 25 | 2017 | Meeta Vyas CFO | 129.6K | — | 99.0K | — | — | — | 228.6K | 43.30% | ↗ |
| 26 | 2017 | Meeta Vyas CFO Appointed May 13, 2013 | 129.6K | — | 99.0K | — | — | — | 228.6K | 43.30% | ↗ |
| 27 | 2016 | Eugene Seymour, CEO, Director | 345.8K | 75.0K | 309.3K | — | — | — | 655.2K | 47.22% | ↗ |
| 28 | 2016 | Anil Diwan President, Director | 345.8K | 75.0K | 309.3K | — | — | — | 655.2K | 47.22% | ↗ |
| 29 | 2016 | Eugene Seymour, Former CEO & Director | 345.8K | 75.0K | 309.3K | — | — | — | 655.2K | 47.22% | ↗ |
| 30 | 2016 | Meeta Vyas CFO Appointed May 13, 2013 | 129.6K | — | 123.7K | — | — | — | 253.3K | 48.83% | ↗ |
| 31 | 2016 | Meeta Vyas CFO | 129.6K | — | 123.7K | — | — | — | 253.3K | 48.83% | ↗ |
| 32 | 2015 | Anil Diwan President, Director | 300.0K | — | 267.9K | — | — | — | 567.9K | 47.17% | ↗ |
| 33 | 2015 | Eugene Seymour, CEO, Director | 300.0K | — | 267.9K | — | — | — | 567.9K | 47.17% | ↗ |
| 34 | 2015 | Meeta Vyas, Interim CFO Appointed May 13, 2013 | 118.8K | — | 223.0K | — | — | — | 341.8K | 65.24% | ↗ |
| 35 | 2015 | Meeta Vyas CFO Appointed May 13, 2013 | 118.8K | — | 223.0K | — | — | — | 341.8K | 65.24% | ↗ |
| 36 | 2015 | Mukund Kulkarni Director Appointed 6/24/13 | 15.0K | — | 15.0K | — | — | — | 30.0K | 50.00% | ↗ |
| 37 | 2015 | Milton Boniuk Director Appointed 5/28/13 | 15.0K | — | 15.0K | — | — | — | 30.0K | 50.00% | ↗ |
| 38 | 2015 | Stanley Glick Director Appointed June 22, 2012. | 15.0K | — | 15.0K | — | — | — | 30.0K | 50.00% | ↗ |
| 39 | 2014 | Anil Diwan President, Director | 291.7K | — | 770.9K | — | — | — | 1.06M | 72.55% | ↗ |
| 40 | 2014 | Eugene Seymour, CEO, Director | 291.7K | — | 770.9K | — | — | — | 1.06M | 72.55% | ↗ |
| 41 | 2014 | Anil Diwan President, Director | 275.0K | — | 187.4K | — | — | — | 462.4K | 40.53% | ↗ |
| 42 | 2014 | Eugene Seymour, CEO, Director | 275.0K | — | 187.4K | — | — | — | 462.4K | 40.53% | ↗ |
| 43 | 2014 | Meeta Vyas, Interim CFO Appointed May 13, 2013 | 108.0K | — | 338.7K | — | — | — | 446.7K | 75.82% | ↗ |
| 44 | 2014 | Meeta Vyas CFO Appointed May 13, 2013 | 108.0K | — | 338.7K | — | — | — | 446.7K | 75.82% | ↗ |
| 45 | 2014 | Meeta Vyas, interim CFO Appointed May 13, 2013 | 108.0K | — | 283.2K | — | — | — | 391.2K | 72.39% | ↗ |
| 46 | 2014 | Milton Boniuk Director Appointed 5/28/13 | 15.0K | — | 15.0K | — | — | — | 30.0K | 50.00% | ↗ |
| 47 | 2014 | Mukund Kulkarni Director Appointed 6/24/13 | 15.0K | — | 15.0K | — | — | — | 30.0K | 50.00% | ↗ |
| 48 | 2014 | Stanley Glick Director* Appointed June 22, 2012. | 15.0K | — | 15.0K | — | — | — | 30.0K | 50.00% | ↗ |
| 49 | 2014 | Stanley Glick Director Appointed June 22, 2012. | 15.0K | — | 11.3K | — | — | — | 30.0K | 37.50% | ↗ |
| 50 | 2014 | Mukund Kulkarni Director Appointed 6/24/13 | 15.0K | — | 15.0K | — | — | — | 30.0K | 50.00% | ↗ |
| 51 | 2014 | Milton Boniuk Director Appointed 5/28/13 | 15.0K | — | 15.0K | — | — | — | 30.0K | 50.00% | ↗ |
| 52 | 2013 | Anil Diwan President, Director | 275.0K | — | 187.4K | — | — | — | 462.4K | 40.53% | ↗ |
| 53 | 2013 | Eugene Seymour, CEO, Director | 275.0K | — | 187.4K | — | — | — | 462.4K | 40.53% | ↗ |
| 54 | 2013 | Anil Diwan President, Director | 275.0K | — | 187.4K | — | — | — | 462.4K | 40.53% | ↗ |
| 55 | 2013 | Eugene Seymour, CEO, Director | 275.0K | — | 187.4K | — | — | — | 462.4K | 40.53% | ↗ |
| 56 | 2013 | Stanley Glick Director* Appointed June 22, 2012. | 11.3K | — | 11.3K | — | — | — | 22.5K | 50.00% | ↗ |
| 57 | 2013 | Stanley Glick Director Appointed June 22, 2012. | 11.3K | — | — | — | — | — | 22.5K | 0.00% | ↗ |
| 58 | 2013 | Meeta Vyas, interim CFO Appointed May 13, 2013 | 12.0K | — | 9.0K | — | — | — | 21.0K | 42.86% | ↗ |
| 59 | 2013 | Meeta Vyas, interim CFO Appointed May 13, 2013 | 12.0K | — | 9.0K | — | — | — | 21.0K | 42.86% | ↗ |
| 60 | 2013 | Meeta Vyas, Interim CFO Appointed May 13, 2013 | 12.0K | — | — | — | — | — | 21.0K | 0.00% | ↗ |
| 61 | 2013 | Mukund Kalkarni Director Appointed 6/24/13 | 3.8K | — | 3.8K | — | — | — | 7.0K | 53.57% | ↗ |
| 62 | 2013 | Milton Boniuk Director Appointed 5/28/13 | 3.8K | — | 3.8K | — | — | — | 7.0K | 53.57% | ↗ |
| 63 | 2013 | Mukund Kulkarni Director Appointed 6/24/13 | 3.8K | — | 3.8K | — | — | — | 7.0K | 53.57% | ↗ |
| 64 | 2013 | Mukund Kulkarni Director Appointed 6/24/13 | 3.8K | — | 3.8K | — | — | — | 7.0K | 53.57% | ↗ |
| 65 | 2013 | Milton Boniuk Director Appointed 5/28/13 | 3.8K | — | 3.8K | — | — | — | 7.0K | 53.57% | ↗ |
| 66 | 2012 | Anil Diwan President, Director | 275.0K | — | 431.5K | — | — | — | 706.5K | 61.07% | ↗ |
| 67 | 2012 | Eugene Seymour, CEO, Director | 275.0K | — | 267.1K | — | — | — | 542.1K | 49.27% | ↗ |
| 68 | 2012 | Stanley Glick Director* Appointed June 22, 2012. | — | — | — | — | — | — | — | — | ↗ |
| 69 | 2012 | Stanley Glick, | — | — | — | — | — | — | — | — | ↗ |
| 70 | 2011 | Anil Diwan President, Director | 275.0K | — | 574.6K | — | — | — | 851.5K | 67.48% | ↗ |
| 71 | 2011 | Eugene Seymour, CEO, Director | 275.0K | — | 574.6K | — | — | 1.9K | 851.5K | 67.48% | ↗ |
| 72 | 2011 | Stanley Glick Director* Appointed June 22, 2012. | — | — | — | — | — | — | — | — | ↗ |
| 73 | 2010 | Eugene Seymour, CEO, Director | 254.2K | — | 513.8K | — | — | — | 768.0K | 66.90% | ↗ |
| 74 | 2010 | Anil Diwan President, Director | 252.0K | — | 513.8K | — | — | — | 765.8K | 67.09% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Anil R. Diwan | Executive Chairman, President, Chief Executive Officer & Secretary | 400.0K | — |
| Meeta R. Vyas | Chief Financial Officer & Compliance Officer | 129.6K | female |
| Randall W. Barton | Chief Scientific Officer | — | — |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
| Transaction Date | Disclosed | Senator | State | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2020-04-07 | 2020-05-01 | Kelly Loeffler | GA | Spouse | Sale (Full) | $1,001 - $15,000 | ↗ |
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for NNVC
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
